FY2025 EPS Estimates for REGENXBIO Cut by Chardan Capital
REGENXBIO Inc. (NASDAQ:RGNX – Free Report) – Analysts at Chardan Capital reduced their FY2025 earnings estimates for shares of REGENXBIO in a research report issued to clients and investors on Monday, March 24th. Chardan Capital analyst D. Gataulin now expects that the biotechnology company will post earnings per share of ($3.03) for the year, down […]
REGENXBIO Inc. (NASDAQ:RGNX – Free Report) – Analysts at Chardan Capital reduced their FY2025 earnings estimates for shares of REGENXBIO in a research report issued to clients and investors on Monday, March 24th. Chardan Capital analyst D. Gataulin now expects that the biotechnology company will post earnings per share of ($3.03) for the year, down […]
